EC Number | Application | Comment | Organism |
---|---|---|---|
1.14.14.154 | drug development | the enzyme is a primary target in treatment of fungal infections in organisms ranging from humans to plants, and development of more potent and selective CYP51 inhibitors is an important biological objective | Mycobacterium tuberculosis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.14.14.154 | CYP51 in complex with 4,4'-dihydroxybenzophenone, enzyme in 20 mM Tris-HCl, pH 7.5, 200 mM NaCl, and 0.5 mM EDTA, is mixed with 4,4'-dihydroxybenzophenone, which is dissolved in Me2SO at 100 mM stock concentration, to final concentrations of 0.2 mM for protein and ligand resulting in needle-like crystals, larger crystals are obtained by hanging drop vapor diffusion method from 1.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, and 2% isopropyl alcohol, cryoprotection by 20% glycerol, X-ray diffraction structure determination and analysis at 1.95 A resolution | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.14.14.154 | 11-ketoestrone | type I binding mechanism | Mycobacterium tuberculosis | |
1.14.14.154 | 2,7-dihydroxy-9-fluorenone | type I binding mechanism | Mycobacterium tuberculosis | |
1.14.14.154 | 4,4'-dihydroxybenzophenone | binds at the active site via a type I mechanism targeting the flexible region, binding structure and kinetics, overview | Mycobacterium tuberculosis | |
1.14.14.154 | estriol | a substrate analogue | Mycobacterium tuberculosis | |
1.14.14.154 | fluconazole | a clinical drug | Mycobacterium tuberculosis |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
1.14.14.154 | Fe2+ | a cytochrome P450 enzyme | Mycobacterium tuberculosis | |
1.14.14.154 | additional information | divalent metal ion is required for the catalytic reaction | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.14.154 | 24,25-dihydrolanosterol + [reduced NADPH-hemoprotein reductase] + O2 | Mycobacterium tuberculosis | - |
(3beta,5alpha)-4,4-dimethylcholesta-8,14-dien-3-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | 24,25-dihydrolanosterol + [reduced NADPH-hemoprotein reductase] + O2 | Mycobacterium tuberculosis H37Rv | - |
(3beta,5alpha)-4,4-dimethylcholesta-8,14-dien-3-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | eburicol + [reduced NADPH-hemoprotein reductase] + O2 | Mycobacterium tuberculosis | - |
? | - |
? | |
1.14.14.154 | eburicol + [reduced NADPH-hemoprotein reductase] + O2 | Mycobacterium tuberculosis H37Rv | - |
? | - |
? | |
1.14.14.154 | lanosterol + [reduced NADPH-hemoprotein reductase] + O2 | Mycobacterium tuberculosis | - |
4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | lanosterol + [reduced NADPH-hemoprotein reductase] + O2 | Mycobacterium tuberculosis H37Rv | - |
4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | obtusifoliol + [reduced NADPH-hemoprotein reductase] + O2 | Mycobacterium tuberculosis | - |
4alpha-methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | obtusifoliol + [reduced NADPH-hemoprotein reductase] + O2 | Mycobacterium tuberculosis H37Rv | - |
4alpha-methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.14.154 | Mycobacterium tuberculosis | P9WPP9 | - |
- |
1.14.14.154 | Mycobacterium tuberculosis H37Rv | P9WPP9 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.14.154 | 24,25-dihydrolanosterol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Mycobacterium tuberculosis | (3beta,5alpha)-4,4-dimethylcholesta-8,14-dien-3-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | 24,25-dihydrolanosterol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Mycobacterium tuberculosis H37Rv | (3beta,5alpha)-4,4-dimethylcholesta-8,14-dien-3-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | eburicol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Mycobacterium tuberculosis | ? | - |
? | |
1.14.14.154 | eburicol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Mycobacterium tuberculosis H37Rv | ? | - |
? | |
1.14.14.154 | lanosterol + O2 + NADPH + H+ | - |
Mycobacterium tuberculosis | 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol + formate + NADP+ + H2O | - |
? | |
1.14.14.154 | lanosterol + O2 + NADPH + H+ | - |
Mycobacterium tuberculosis H37Rv | 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol + formate + NADP+ + H2O | - |
? | |
1.14.14.154 | lanosterol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Mycobacterium tuberculosis | 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | lanosterol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Mycobacterium tuberculosis H37Rv | 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | obtusifoliol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Mycobacterium tuberculosis | 4alpha-methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
1.14.14.154 | obtusifoliol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Mycobacterium tuberculosis H37Rv | 4alpha-methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol + formate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.14.14.154 | More | three-dimensional modeling | Mycobacterium tuberculosis |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.14.14.154 | CYP51 | - |
Mycobacterium tuberculosis |
1.14.14.154 | sterol 14alpha-demethylase | - |
Mycobacterium tuberculosis |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.14.14.154 | 37 | - |
assay at | Mycobacterium tuberculosis |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.14.14.154 | 7.5 | - |
assay at | Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.14.14.154 | cytochrome P450 | a cytochrome P450 enzyme | Mycobacterium tuberculosis |